{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-24-000088","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.482057+00:00","generated_at":"2026-06-01T04:05:04.528841+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Cartesian stockholders elect directors, approve incentive plan, ratify auditor at annual meeting","bullets":["Carrie S. Cox (11.8M for) and Murat Kalayoglu (12.1M for) elected to Class II board until 2027.","Stockholders approved amended & restated 2016 Incentive Award Plan (11.3M for, 857K against).","Non-binding advisory vote on executive compensation passed (11.7M for, 444K against).","Ernst & Young ratified as independent auditor for 2024 (13.5M for, 212K against).","Annual meeting turnout: 13.8M shares voted, ~77.3% of outstanding common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-24-000088","json":"https://secwatch.observer/filing/0001453687-24-000088.json","markdown":"https://secwatch.observer/filing/0001453687-24-000088.md","text":"https://secwatch.observer/filing/0001453687-24-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000088/0001453687-24-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000088/rnac-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:05:04.528841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}